Erythrocyte Na/K ATPase activity and diabetes: Relationship with C- peptide level

Diabetologia

Volumn 41, Issue 9, 1998, Pages 1080-1084

  Dufayet De La Tour, D ^a   Raccah, D ^a   Jannot, M F ^a   Coste, T ^a   Rougerie, C ^a   Vague, P ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

C peptide; Human erythrocyte; Na K ATPase activity; Type I diabetes mellitus; Type II diabetes mellitus

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); C PEPTIDE; ERYTHROCYTE ENZYME; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NA(+)-K(+)-EXCHANGING ATPASE; REGRESSION ANALYSIS;

EID: 0031873313     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051033     Document Type: Article

References (27)

1. Greene DA, Lattimer SA, Sima AAF (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599-605
2. Raccah D, Jannot MF, Issautier D, Vague P (1994) Effect of experimental diabetes on Na/K ATPase activity in red blood cells, peripheral nerve and kidney. Diabet Metab 20: 271-274
3. Raccah D, Gallice P, Pouget J, Vague P (1992) Hypothesis low Na/K ATPase activities of the red cell membrane, a potential marker of the predisposition to diabetic neuropathy. Diabet Metab 18: 236-241
4. + AT-Pase activity in Type I (insulin-dependent) diabetic subjects and its activation by homologous plasma. Diabetes 36: 991-995
5. Raccah D, Fabreguettes C, Azulay JP, Vague P (1996) Erythrocyte Na/K ATPase activity, metabolic control and neuropathy in insulin dependent diabetic patients. Diabetes Care 19: 564-568
6. Vague P, Dufayet D, Coste T, Moriscot C, Jannot MF, Raccah D (1997) Association of diabetic neuropathy with Na/K ATPase gene polymorphism. Diabetologia 40: 506-511
7. Wahren J, Ohtomo Y, Johansson BL, Bergmann T, Aperia A, Jörnvall H (1497) C-peptide fragments stimulate renal tubule Na + K + -ATPase activity (Diabetologia 40 [supply 1]:150A (Abstract)
8. Johansson BL, Sjöberg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilization in Type I (insulin-dependent) diabetic patients. Diabetologia 35: 121-128
9. Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J (1996) C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39: 687-695
10. Beutler E, Kuhl E, Sacks P (1983) Sodium potassium ATPase activity is influenced by ethnic origin and not by obesity. N Engl J Med 309: 756-760
11. DCCT Research Group (1988) Factors in the development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of diabetic control and complications trials. Diabetes 37: 471-481
12. Beutler E, West C, Blume KG (1976) The removal of leucocytes and platelets from whole blood. J Lab Clin Med 88: 328-333
13. Bozzo C, Goria M, Marengo C, Marena S, Veglia F, Pagano G (1990) Lymphocyte Na/K ATPase is reduced in aged people. Metabolism 39: 808-814
14. Mimura M, Makino H, Kanatsuka A, Asai T, Yoshida S (1994) Na/K ATPase activity in Type 2 (non-insulin-dependent) diabetic patients with microalbumineria. Horm Metab Res 26: 33-38
15. Ribalet B, Mirell CJ, Johnson DG, Levin SR (1996) Sulphonylurea binding to a low affinity site inhibits the Na/K ATPase and KATP channel in insulin secreting cells. Journal of General Physiology 107: 231-241
16. Rahmani-Jourdheuil D, Mourayre Y, Vague P, Boyer J, Juhan-Vague I (1987) In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabetics. Diabetes 36: 991-995
17. Wahren J, Johansson BL, Wallberg-Henricksson H (1994) Does C-peptide have a physiological role? Diabetologia 37 [suppl 2]:S99-S107
18. Johansson BL, Kernell A, Sjöberg S, Wahren J (1993) Influence of C-peptide and insulin administration on renal function and metabolic control in diabetes Type I. J Clin Endocrinol Metab 77(4): 976-981
19. Zierath JR, Galuska D, Johansson BL, Wallberg-Henricksson H (1991) Effect of human C-peptide on glucose transport in vitro incubated human skeletal muscle. Diabetologia 34: 899-901
20. Wòjcikowski C, Maier V, Dominiak K, Fussgänger R, Pfeiffer EF (1983) Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia 25: 288-290
21. Wahren J, Bertorello A, Kahn SE, Verchere CB, Johansson BL, Halban PA (1997) Intact but not truncated des(27-31) rat C-peptide stimulates β-cell Na + K + -ATPase activity. Diabetologia 40 [suppl 1]: 150A (Abstract)
22. Ohtomo Y, Aperia A, Sahlgren B, Johansson BL, Wahren J (1996) C-peptide stimulates rat renal tubular Na + ,K + -ATPase activity in synergism with neuropeptide Y. Diabetologia 39: 199-205
23. Steiner D, Rubenstein A (1997) Proinsulin C-peptide - Biological activity? Science 277: 531-532
24. Ido Y, Vindigni A, Chang K et al. (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277: 583-586
25. Flatt PR, Swanston-Flatt SK, Hampton SM, Bailey CJ, Marks V (1986) Specific binding of C-peptide of proinsuline to cultured β-cells from a transplantable rat islet cell tumor. Biosci Rep 6: 193-199
26. Lytton J, Lin J, Di-Antonio L et al. (1994) Regulation of the Na + K + ATPase pump by insulin. In: Bamberg E, Schoner W (eds) The sodium pump structure, mechanism, hormonal control and its role in disease. Steinkopff, Darmstadt, Springer, New York, pp 670-681
27. Häring HU, Kellerer M, Mosthaf L (1994) Modulation of insulin receptor signalling: significance of altered receptor isoform patterns and mechanism of hyperglycaemia-induced receptor modulation. Diabetologia 37 [suppl 2]: S149-S154